Programmed death ligand-1 over-expression correlates with malignancy and contributes to immune regulation in ovarian cancer

Christian J. Maine, Sadaf Ghaem‐Maghami, Jayanta Chatterjee et al.|Cancer Immunology Immunotherapy|2013

Cited by 126